Independent news has never been so important.

Did you know that you can get Democracy Now! delivered to your inbox every day? Sign up for our Daily News Digest today! Don't worry, we'll never share or sell your information.

Pfizer: Vaccine 80% Effective Against Symptomatic Omicron Infection in Young Kids

HeadlineMay 24, 2022

Pfizer reported Monday that three smaller-sized doses of its COVID-19 vaccine were safe and effective at preventing symptomatic illness in children under the age of 5. Pfizer’s announcement came as it prepared to submit a request for emergency use of its pediatric vaccine for U.S. children as young as 6 months old. Approval could come after the FDA convenes a panel of independent vaccine experts on June 15, when the agency will also consider Moderna’s application for emergency use of its vaccine in young children.

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation